ofloxacin has been researched along with lactic acid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Kudoh, M; Ohkubo, T; Otani, K; Sasaki, J; Sawada, Y; Sugawara, K | 1 |
| Anastasiadis, A; Andreopoulos, AG; Dounis, E; Kanellakopoulou, K; Korakis, T; Tzivelekis, P | 1 |
| Hallanvuo, S; Multanen, M; Seppälä, J; Siitonen, A; Talja, M; Tammela, TL; Törmälä, P; Välimaa, T | 1 |
| Järvi, K; Multanen, M; Seppälä, J; Talja, M; Tammela, TL; Törmälä, P; Välimaa, T | 1 |
| Davis, ME; Mack, BC; Wright, KW | 1 |
| Ali, A; Aqil, M; Bhatnagar, A; Gupta, H; Khar, RK; Mittal, G | 1 |
| Cheow, WS; Hadinoto, K | 1 |
| Cheow, WS; Hadinoto, K; Kho, K; Wang, Y | 1 |
| Khuller, GK; Kumar, G; Malhotra, S; Shafiq, N; Sharma, S | 1 |
| Iqbal, Z; Jamal, T; Mirza, MA; Panda, AK; Rahman, MA; Talegaonkar, S | 1 |
| Chooi, WH; Gan, CW; Lim, LH; Ng, HC; Venkatraman, SS; Wong, YS | 1 |
| Chen, L; Li, H; Wang, YJ; Wu, G | 1 |
| Chen, L; Chen, XF; Deng, CL; Li, H; Wu, G | 1 |
| Blasi, P; Di Michele, A; Giovagnoli, S; Palazzo, F; Ricci, M; Schoubben, A | 1 |
15 other study(ies) available for ofloxacin and lactic acid
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
An evaluation of a new lactic acid polymer drug delivery system: a preliminary report.
Topics: Animals; Drug Delivery Systems; Female; Lactates; Lactic Acid; Microbial Sensitivity Tests; Ofloxacin; Polyesters; Polymers; Pseudomonas aeruginosa; Pyrones; Rats; Staphylococcus aureus; Wound Infection | 1994 |
In vitro release of new quinolones from biodegradable systems: a comparative study.
Topics: Anti-Infective Agents; Biodegradation, Environmental; Ciprofloxacin; Culture Media; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Delivery Systems; In Vitro Techniques; Lactic Acid; Molecular Weight; Ofloxacin; Polyesters; Polymers; Time Factors | 1996 |
Bacterial adherence to ofloxacin-blended polylactone-coated self-reinforced L-lactic acid polymer urological stents.
Topics: Anti-Infective Agents, Urinary; Bacterial Adhesion; Equipment Contamination; Humans; Lactic Acid; Ofloxacin; Stents; Urinary Catheterization | 2000 |
Biocompatibility of silver nitrate and ofloxacine coated bioabsorbable SR-PLLA rods.
Topics: Absorbable Implants; Animals; Anti-Infective Agents, Urinary; Coated Materials, Biocompatible; Lactic Acid; Male; Ofloxacin; Polymers; Rabbits; Silver Nitrate; Stents | 2001 |
A biodegradable filament for controlled drug delivery.
Topics: Absorbable Implants; Administration, Topical; Animals; Chemistry, Pharmaceutical; Conjunctiva; Delayed-Action Preparations; Dexamethasone; Dimethyl Sulfoxide; Drug Carriers; Drug Compounding; Lactic Acid; Levofloxacin; Ofloxacin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Solubility; Solvents; Surface Properties; Tears; Tensile Strength; Transition Temperature | 2009 |
Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Calorimetry, Differential Scanning; Chickens; Chorioallantoic Membrane; Cornea; Drug Carriers; Drug Stability; Goats; Lactic Acid; Levofloxacin; Microbial Sensitivity Tests; Nanoparticles; Ofloxacin; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Spectrophotometry, Infrared; Staphylococcus aureus; Surface Properties; X-Ray Diffraction | 2011 |
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Compounding; Drug Delivery Systems; Drug Stability; Lactic Acid; Levofloxacin; Lipids; Microscopy, Electron, Scanning; Nanoparticles; Ofloxacin; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Surface-Active Agents; Vitamin E; Water | 2011 |
A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
Topics: Desiccation; Drug Compounding; Dry Powder Inhalers; Excipients; Freeze Drying; Lactic Acid; Lecithins; Leucine; Levofloxacin; Mannitol; Microscopy, Electron, Scanning; Nanoparticles; Ofloxacin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol | 2012 |
Optimization, in vitro-in vivo evaluation, and short-term tolerability of novel levofloxacin-loaded PLGA nanoparticle formulation.
Topics: Animals; Antitubercular Agents; Area Under Curve; In Vitro Techniques; Lactic Acid; Levofloxacin; Mice; Microscopy, Electron, Scanning; Nanoparticles; Ofloxacin; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Tissue Distribution | 2012 |
Formulation, antimicrobial and toxicity evaluation of bioceramic based ofloxacin loaded biodegradable microspheres for periodontal infection.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Chemistry, Pharmaceutical; Escherichia coli; Escherichia coli Infections; Lactic Acid; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Microspheres; NIH 3T3 Cells; Ofloxacin; Particle Size; Periodontal Diseases; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcal Infections; Staphylococcus aureus | 2012 |
Development of a novel biodegradable drug-eluting ventilation tube for chronic otitis media with effusion.
Topics: Animals; Coated Materials, Biocompatible; Guinea Pigs; Lactic Acid; Middle Ear Ventilation; Ofloxacin; Otitis Media with Effusion; Otoscopy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation | 2013 |
Hyaluronic acid as an internal phase additive to obtain ofloxacin/PLGA microsphere by double emulsion method.
Topics: Adsorption; Anti-Bacterial Agents; Calibration; Drug Delivery Systems; Electrolytes; Emulsions; Hyaluronic Acid; Lactic Acid; Lasers; Microspheres; Ofloxacin; Oils; Osmotic Pressure; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Shear Strength; Solvents; Static Electricity; Stress, Mechanical; Water | 2014 |
Comparing microspheres with different internal phase of polyelectrolyte as local drug delivery system for bone tuberculosis therapy.
Topics: Drug Delivery Systems; Emulsions; Hyaluronic Acid; Lactic Acid; Microspheres; Ofloxacin; Oils; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polylysine; Polymers; Solvents; Tuberculosis, Osteoarticular; Water | 2014 |
The influence of feedstock and process variables on the encapsulation of drug suspensions by spray-drying in fast drying regime: the case of novel antitubercular drug–palladium complex containing polymeric microparticles.
Topics: Antitubercular Agents; Capreomycin; Coordination Complexes; Desiccation; Drug Compounding; Excipients; Lactic Acid; Ofloxacin; Palladium; Particle Size; Polyesters; Polymers; Solubility; Suspensions | 2014 |